Penelope Bourbon Commits $250,000 to FCancer as Partnership Marks Fifth Anniversary

The brand also unveils FCancer Batch 5, a limited edition, six-year-old blend of straight whiskeys available nationwide this month

ST. LOUIS--(BUSINESS WIRE)--Penelope Bourbon is marking five years of its partnership with FCancer with the release of Batch 5, a six-year-old blend of straight whiskeys available at select retailers nationwide starting this October. The annual limited release reflects Penelope’s ongoing commitment to supporting FCancer’s mission of changing the way people think about cancer through prevention, early detection and support. This year, Penelope is pledging $250,000 to the nonprofit.

The partnership with FCancer began when the Penelope team created a blend in honor of a teammate who lost someone they loved to cancer. Five years later, the annual release has become an opportunity to honor those affected by the disease while helping FCancer advance its work. Each release features bold label artwork of multicolored ribbons, representing the many forms cancer takes and the many people it touches.

"Five years ago, the goal was to create a whiskey to honor our colleague's late wife who was lost to cancer. It was an opportunity to bring people together while also supporting FCancer's incredible mission," said Michael Paladini, founder and vice president of strategy at Penelope Bourbon. “Blending Batch 5 alongside the FCancer team, cancer survivors, and friends of the brand makes this year’s bottle even more special.”

Bottled at 101 proof and aged six years, Penelope Bourbon FCancer Batch 5 is distilled in Lawrenceburg, Indiana, and features a four-grain mash bill of 64% corn, 20% rye, 1% malted rye and 15% barley malt. Made in small batches, the whiskey opens with notes of toffee, vanilla bean, baked apple and toasted grain on the nose, followed by brown sugar, honeyed corn, cinnamon and malt on the palate. The finish carries caramel, charred oak, dark chocolate, and warm spice.

“For this release, we brought together six-year-aged bourbon and American malt whiskey to create a blend with its own unique character,” said Danny Polise, founder and master blender of Penelope Bourbon. “Each component was carefully selected for what it contributes to the final blend, resulting in a well-balanced whiskey with great depth and complexity. It makes this release even more meaningful knowing it’s supporting such an important cause.”

Penelope's partnership with FCancer provides an important opportunity to spotlight the role of prevention and early detection while supporting the individuals and families affected by cancer. Through education and access to screening resources, FCancer works to empower people to take a proactive approach to their health and improve outcomes.

"Penelope has been an extraordinary partner and their commitment to supporting FCancer grows stronger every year," said Julie Greenbaum, co-founder and chief revenue officer of FCancer. "This year's pledge will help us reach more people with the education, early detection resources, and support they need. During Breast Cancer Awareness Month especially, we are grateful to Penelope and everyone who raises a glass to help us change the conversation around cancer."

Penelope Bourbon FCancer Batch 5 is available for purchase at select retailers nationwide, while supplies last, for a suggested retail price of $79.99. For more information on Penelope Bourbon, visit penelopebourbon.com or follow @penelopebourbon on Instagram.

About Penelope Bourbon

Founded in 2018, Penelope Bourbon has become one of the fastest-growing, award-winning premium whiskey brands. We offer a range of uniquely blended and finished straight bourbon and whiskey expressions known for their smoothness and rich flavor, and premium handcrafted ready-to-serve cocktails. Our products have won many spirits industry awards including Best in Class finalist and a Double Gold medal for Toasted at the 2025 San Francisco World Spirits Competition. Wheated earned a Double Platinum medal and Peach Old Fashioned and Black Walnut Old Fashioned ready-to-pour cocktails earned Platinum medals at the 2025 ASCOT Awards. We continue to innovate within our Cooper Series, Limited Releases and Estate Collection to further establish our place among the top premium whiskey brands and prove that with passion, dedication, and love, anything is possible. For more information, visit PenelopeBourbon.com and follow on Facebook, Instagram and TikTok.

About Luxco

Luxco is a leading producer, supplier, importer and bottler of beverage alcohol products with a mission to meet the needs and exceed the expectations of consumers, associates, and business partners. Luxco operates as the Branded Spirits business unit of MGP Ingredients Inc. (Nasdaq: MGPI). The company’s extensive and award-winning premium portfolio includes brands from four distilleries: MGP Distillery in Lawrenceburg, Indiana, where MGP Bourbon, Penelope and Remus bourbon are produced; Bardstown, Kentucky-based Lux Row Distillers, home of Rebel, Ezra Brooks, and Blood Oath bourbons; Lebanon, Kentucky-based Limestone Branch Distillery, maker of Yellowstone Bourbon; and Arandas, Mexico-based Destiladora Gonzalez Lux, producer of 100% agave tequilas including Cortada, El Mayor, Escasa, and Exotico. For more information, visit Luxco.com.

About FCancer

FCancer is dedicated to advancing health equity through early detection and prevention programs and by providing resources to navigate, manage, and cope with cancer letsfcancer.com @letsfcancer / @fcancernow.

Billions of dollars have been spent on finding the cure for cancer, while funding for prevention, early detection and support has largely been neglected. FCancer aims to fill this gap by:

• Funding clinic navigators in high-risk communities to connect patients with HPV vaccines to prevent cancer and screenings to find breast, cervical, colorectal, and lung cancer early.
• Offering tangible and emotional support programs to make life with cancer easier.
• Working hard to help people take control of their health. FCancer's education initiatives spread the word about the importance of cancer prevention and early detection, and offer some support along the way.